Turn Therapeutics (TTRX) Intangibles (2024 - 2026)

Turn Therapeutics' quarterly Intangibles came in at $919947.0 in Q1 2026, little changed quarter-over-quarter from $922171.0 in Q4 2025.

Turn Therapeutics has reported Intangibles for 3 years, with the latest figure at $919947.0 in Q1 2026.

  • For the quarter ending Q1 2026, Intangibles changed N/A year-over-year to $919947.0; the trailing twelve-month figure through Mar 2026 stood at $919947.0 (changed N/A YoY), and the FY2025 full-year result was $922171.0, down 10.18% from the prior year.
  • Intangibles for Q1 2026 stood at $919947.0, roughly flat from $922171.0 in the prior quarter.
  • The five-year high for Intangibles was $1.0 million in Q4 2024, with the low at $904885.0 in Q3 2025.
  • Average Intangibles over 3 years is $943429.8, with a median of $921059.0 recorded in 2025.
  • Peak annual rise in Intangibles reached 10.18% in 2025, while the deepest fall reached 10.18% in 2025.
  • Tracing TTRX's Intangibles over 3 years: stood at $1.0 million in 2024, then fell by 10.18% to $922171.0 in 2025, then fell by 0.24% to $919947.0 in 2026.
  • The last three Intangibles figures came in at $919947.0 (Q1 2026), $922171.0 (Q4 2025), and $904885.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 4.41 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 11,640.44
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 418.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 1.29 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Turn Therapeutics 188.06 Mn 188.06 Mn - 919,947.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 919,947.00
Dec 31, 2025 922,171.00
Sep 30, 2025 904,885.00
Dec 31, 2024 1.03 Mn